Alira Health

EPA World Congress 2022

March 22-24, 2022, Amsterdam
Events
Category:
Published on:
February 2, 2022

We are thrilled to sponsor and attend World EPA Congress 2022, Europe’s Leading Pricing, Market Access and Evidence Congress for the Biopharma Industry.

The event will feature 250 speakers, multiple streams, and over 1000 attendees from pharma, biotech, and Payers/HTA’s. The 2022 edition will now take place over three days with expanded content on RWE, HTA, Medical Devices, Affordability, Digital Health, Analytics and Emerging Markets. The event’s core topic areas will include Market Access and Pricing, Rare Diseases, HTA/Payer, and Evidence and will cover the latest trends in reimbursement, payment models, affordability, HEOR, and many other developments within the industry.

As part of the event, our very own Andrea Mantovani, Vice President, Global Market Access will also host a roundtable “Next Generation Therapies: Access, Pricing and Ethical Issues in Perspective”.

Our attendees:

 

Related news

Webinars March 28, 2025
How Sustainability and Health Equity Are Reshaping Market Access Policy in Europe
This webinar will explore sustainability and health equity impact on reimbursement and procurement decisions in Europe and provide practical insights on how companies can adapt to the new landscape.
EU Market Access Sustainability
Articles March 6, 2025
ATMPs: Access, Pricing, and Ethical Issues in Perspective
Start reading this sneak peek of our recent analysis of access, pricing and ethical issues for advanced therapies medicinal products.
Advanced Therapies Market Access Orphan Drug Pricing
Articles February 17, 2025
Sustainable Pricing: An Opportunity to Improve Patient Access
Discover key pricing strategies to improve pharmaceutical health equity and price sustainability.
Market Access Pricing Sustainability
Articles January 24, 2025
How to Navigate the JCA Era: Market Access Strategy Optimization in the EU
With the JCA now in effect, we spoke with Andrea Mantovani, Alira Health Partner, Market Access and Pricing, about its impact on pharmaceutical companies hoping to bring new therapies to market.
EU Market Access
News January 8, 2025
Alira Health Launches the Global Payer Forum 2025 in Partnership with UPF Barcelona School of Management, NEWDIGS at Tufts Medical Center, and the University College of London
Alira Health is excited to announce the second year of the Global Payer Forum, a landmark educational initiative in partnership with distinguished academic institutions, UPF Barcelona(...)
Health Policy Market Access Pharma
Articles December 18, 2024
Market Access and Pricing Landscape for Diagnostic Radiopharmaceuticals
Discover the current market access and pricing landscape for diagnostic radiopharmaceuticals in key European markets, including the specific challenges, and discusses best practices(...)
Market Access Pricing Radiopharmaceuticals
Articles November 12, 2024
Funding and Procurement Trends in Radiopharmaceuticals
Discover how funding and procurement processes for commercial radiopharmaceuticals vary across Europe, including factors driving purchasing decisions.
Market Access Nuclear Medicine Radioligand Therapies (RLTs)
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.